Structural basis of NSD2 degradation via targeted recruitment of SCF-FBXO22

K Kevin C. Robertson S Sascha J. Amann (Research Institute of Molecular Pathology, Vienna BioCenter) T Tongkun Liu A Adam V. Funk X Xianxi Wang (Department of Pharmacology and Lineberger Comprehensive Cancer Center, The University of North Carolina) I Irina Grishkovskaya (Research Institute of Molecular Pathology, Vienna BioCenter) A Aamir Mehmood J John R. Tabor J Jacqueline L. Norris-Drouin C Cheryl H. Arrowsmith J Jon L. Collins Y Yinglong Miao M Michael J. Emanuele D David Haselbach (Research Institute of Molecular Pathology, Vienna BioCenter) L Lindsey I. James N Nicholas G. Brown

Abstract

Abstract Targeted protein degradation (TPD) through the ubiquitin-proteasome system is driven by compound-mediated polyubiquitination of a protein-of-interest by an E3 ubiquitin (Ub) ligase. Relatively few E3s have been successfully utilized for TPD and the governing principles of functional ternary complex formation between the E3, degrader, and protein target remain elusive. FBXO22 has recently been harnessed for TPD applications by degraders that covalently modify its cysteine residues. Here, we reveal that the aldehyde derivative of UNC10088 promotes cooperative binding of FBXO22 to NSD2, a histone methyltransferase and oncogenic protein, leading to a cryo-EM structure of the SKP1-CUL1-F-box (SCF)-FBXO22 complex with NSD2. This structure revealed a conformational change in the FBXO22 loop surrounding C326, further exposing the cysteine for covalent recruitment. Additional medicinal chemistry efforts led to the discovery of benzaldehyde-based non-prodrug degraders that similarly engage C326 of FBXO22 and potently degrade NSD2. Unlike many degraders, our molecules recruit NSD2 to a different surface of FBXO22 than the known FBXO22 substrate BACH1, allowing for concurrent complex formation and structural determination of SCF FBXO22 bound to both the neosubstrate NSD2 and native substrate BACH1. Overall, we demonstrate the biochemical and structural basis for NSD2 degradation, revealing key principles for efficient and selective TPD by SCF FBXO22 .

Article Details

Volume / Issue Vol. 17, Issue 1
Published April 23, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (16)

K

Kevin C. Robertson

S

Sascha J. Amann

Research Institute of Molecular Pathology, Vienna BioCenter

T

Tongkun Liu

A

Adam V. Funk

X

Xianxi Wang

Department of Pharmacology and Lineberger Comprehensive Cancer Center, The University of North Carolina

I

Irina Grishkovskaya

Research Institute of Molecular Pathology, Vienna BioCenter

A

Aamir Mehmood

J

John R. Tabor

J

Jacqueline L. Norris-Drouin

C

Cheryl H. Arrowsmith

J

Jon L. Collins

Y

Yinglong Miao

M

Michael J. Emanuele

D

David Haselbach

Research Institute of Molecular Pathology, Vienna BioCenter

L

Lindsey I. James

N

Nicholas G. Brown